Latest On G1 Therapeutics, Inc (GTHX):
About G1 Therapeutics, Inc (GTHX):
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer, as well as Phase II clinical trials for the treatment of neoadjuvant breast cancer; lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, which is in Phase IIa clinical trials for the treatment of estrogen receptor-positive and HER2-negative breast cancer. The company has a collaboration with Quantum Leap Healthcare Collaborative to evaluate trilaciclib for neoadjuvant treatment of locally advanced breast cancer; and license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was founded in 2008 and is headquartered in Research Triangle Park, North Carolina.
General
- Name G1 Therapeutics, Inc
- Symbol GTHX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 122
- Fiscal Year EndDecember
- IPO Date2017-05-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.g1therapeutics.com
Valuation
- Price/Sales (Trailing 12 Mt.) 19.1
- Price/Book (Most Recent Quarter) 5.4
- Enterprise Value Revenue 17.19
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$4.20
- Next Year EPS Estimate -$3.55
- Next Quarter EPS Estimate -$1.04
- Profit Margin -219%
- Operating Margin -213%
- Return on Assets -23%
- Return on Equity -46%
- Revenue 45.29 million
- Earnings Per Share -$2.70
- Revenue Per Share $1.2
- Gross Profit 45.29 million
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 950.38 million
- EBITDA -105136000
- Analyst Target Price $59
- Book Value Per Share $4.65
Share Statistics
- Shares Outstanding 41.96 million
- Shares Float 35.04 million
- % Held by Insiders 1040%
- % Held by Institutions 90.9%
- Shares Short 6.33 million
- Shares Short Prior Month 5.22 million
- Short Ratio 2.9
- Short % of Float 23%
- Short % of Shares Outstanding 15%
Technicals
- Beta 2.33
- 52 Week High $37.07
- 52 Week Low $9.43
- 50 Day Moving Average 25.1
- 200 Day Moving Average 18.03
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
G1 Therapeutics, Inc (GTHX) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
G1 Therapeutics, Inc (GTHX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-24 | $N/A | -$0.67 | -$0.90 | 25.43% |
2020-09-30 | 2020-11-04 | $N/A | -$0.31 | -$0.30 | -1.84% |
2020-06-30 | 2020-08-05 | $N/A | -$0.83 | -$0.83 | -0.14% |
2020-03-31 | 2020-05-06 | $N/A | -$0.82 | -$0.98 | 16.03% |
2019-12-31 | 2020-02-26 | $N/A | -$0.94 | -$0.96 | 2.08% |
2019-09-30 | 2019-11-05 | $N/A | -$0.86 | -$0.85 | -0.87% |
2019-06-30 | 2019-08-07 | $N/A | -$0.82 | -$0.72 | -13.2% |
2019-03-31 | 2019-05-09 | $N/A | -$0.64 | -$0.72 | 11.15% |
2018-12-31 | 2019-02-28 | $N/A | -$0.65 | -$0.57 | -14.36% |
2018-09-30 | 2018-11-07 | $N/A | -$0.59 | -$0.68 | 12.59% |
2018-06-30 | 2018-08-08 | $N/A | -$0.64 | -$0.65 | 1.61% |
2018-03-31 | 2018-05-03 | $N/A | -$0.70 | -$0.61 | -15.55% |
2017-12-31 | 2018-02-21 | $N/A | -$0.60 | -$0.57 | -4.66% |
2017-09-30 | 2017-11-08 | $N/A | -$0.55 | -$0.55 | -0.22% |
2017-06-30 | 2017-08-09 | $N/A | -$0.55 | -$0.51 | -7.05% |
2017-03-31 | 2017-05-23 | $N/A | -$0.59 | -$0.60 | 1.55% |
G1 Therapeutics, Inc (GTHX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
G1 Therapeutics, Inc (GTHX) Chart:
G1 Therapeutics, Inc (GTHX) News:
Below you will find a list of latest news for G1 Therapeutics, Inc (GTHX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
G1 Therapeutics, Inc (GTHX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 0.5 | 0 | CALL | 0 | 0 | 717.4 | TRUE | 0 | 0 |
2024-04-19 | 1 | 0 | CALL | 0 | 0 | 439.25 | TRUE | 0 | 0 |
2024-04-19 | 1.5 | 1.4 | CALL | 0 | 0 | 373.29 | TRUE | 0 | 0 |
2024-04-19 | 2 | 0 | CALL | 0 | 0 | 404.38 | TRUE | 0 | 0 |
2024-04-19 | 2.5 | 2.25 | CALL | 198 | 7835 | 141.58 | TRUE | 2.25 | 0 |
2024-04-19 | 3 | 1.17 | CALL | 0 | 5 | 122.12 | TRUE | 0 | 0 |
2024-04-19 | 3.5 | 0.85 | CALL | 0 | 183 | 125.38 | TRUE | 0 | 0 |
2024-04-19 | 4 | 0.63 | CALL | 0 | 189 | 172.3 | TRUE | 0 | 0 |
2024-04-19 | 4.5 | 0.65 | CALL | 1 | 48 | 150.84 | FALSE | 0.2 | 0.44 |
2024-04-19 | 5 | 0.32 | CALL | 505 | 12805 | 116.81 | FALSE | 0.07 | 0.28 |
2024-04-19 | 5.5 | 0.36 | CALL | 759 | 1429 | 110.65 | FALSE | 0.16 | 0.8 |
2024-04-19 | 7.5 | 0.04 | CALL | 760 | 3799 | 129.09 | FALSE | 0.02 | 1 |
2024-04-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2.5 | 0.05 | PUT | 0 | 1589 | 0 | FALSE | 0 | 0 |
2024-04-19 | 3 | 0.08 | PUT | 12 | 33 | 143.09 | FALSE | 0.08 | 0 |
2024-04-19 | 3.5 | 0.55 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
2024-04-19 | 4 | 0.27 | PUT | 4 | 3 | 114.5 | FALSE | 0.27 | 0 |
2024-04-19 | 4.5 | 0.5 | PUT | 1 | 3 | 112.34 | TRUE | 0.5 | 0 |
2024-04-19 | 5 | 0.95 | PUT | 0 | 1814 | 114.26 | TRUE | 0 | 0 |
2024-04-19 | 5.5 | 0 | PUT | 0 | 0 | 126.62 | TRUE | 0 | 0 |
2024-04-19 | 7.5 | 5.8 | PUT | 0 | 0 | 200.49 | TRUE | 0 | 0 |
2024-05-17 | 1.5 | 0 | CALL | 0 | 0 | 585.35 | TRUE | 0 | 0 |
2024-05-17 | 2 | 0 | CALL | 0 | 0 | 141.66 | TRUE | 0 | 0 |
2024-05-17 | 2.5 | 2.28 | CALL | 0 | 0 | 359.72 | TRUE | 0 | 0 |
2024-05-17 | 3 | 0 | CALL | 0 | 0 | 241.23 | TRUE | 0 | 0 |
2024-05-17 | 3.5 | 1.05 | CALL | 0 | 2 | 345.25 | TRUE | 0 | 0 |
2024-05-17 | 4 | 0.8 | CALL | 0 | 29 | 159.72 | TRUE | 0 | 0 |
2024-05-17 | 4.5 | 0.75 | CALL | 1 | 0 | 114.24 | FALSE | 0.75 | 0 |
2024-05-17 | 5 | 0.75 | CALL | 29 | 1 | 141.98 | FALSE | 0.25 | 0.5 |
2024-05-17 | 5.5 | 0.15 | CALL | 0 | 5 | 141.06 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 134.73 | FALSE | 0 | 0 |
2024-05-17 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0.25 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
2024-05-17 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 3.5 | 0.95 | PUT | 0 | 10 | 107.85 | FALSE | 0 | 0 |
2024-05-17 | 4 | 0.71 | PUT | 0 | 15 | 0 | FALSE | 0 | 0 |
2024-05-17 | 4.5 | 0.71 | PUT | 1 | 0 | 108.21 | TRUE | 0.71 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 108.36 | TRUE | 0 | 0 |
2024-05-17 | 5.5 | 0 | PUT | 0 | 0 | 106.94 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 279.59 | TRUE | 0 | 0 |
2024-07-19 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-07-19 | 1 | 0 | CALL | 0 | 0 | 361.15 | TRUE | 0 | 0 |
2024-07-19 | 1.5 | 0 | CALL | 0 | 0 | 337 | TRUE | 0 | 0 |
2024-07-19 | 2 | 0 | CALL | 0 | 0 | 279.01 | TRUE | 0 | 0 |
2024-07-19 | 2.5 | 2.2 | CALL | 23 | 2543 | 113.77 | TRUE | 0.05 | 0.02 |
2024-07-19 | 3 | 1 | CALL | 0 | 10 | 115.57 | TRUE | 0 | 0 |
2024-07-19 | 3.5 | 1.65 | CALL | 1 | 100 | 123.45 | TRUE | 1.65 | 0 |
2024-07-19 | 4 | 1.35 | CALL | 2 | 1 | 115.78 | TRUE | 1.35 | 0 |
2024-07-19 | 4.5 | 0 | CALL | 0 | 0 | 275.77 | FALSE | 0 | 0 |
2024-07-19 | 5 | 1.15 | CALL | 25 | 494 | 133.82 | FALSE | 0.2 | 0.21 |
2024-07-19 | 5.5 | 0.6 | CALL | 0 | 1 | 307.92 | FALSE | 0 | 0 |
2024-07-19 | 7.5 | 0.62 | CALL | 81 | 2026 | 134.27 | FALSE | 0.12 | 0.24 |
2024-07-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 2 | 0.25 | PUT | 0 | 20 | 142.57 | FALSE | 0 | 0 |
2024-07-19 | 2.5 | 0.34 | PUT | 0 | 414 | 126.77 | FALSE | 0 | 0 |
2024-07-19 | 3 | 0.65 | PUT | 0 | 4 | 134.16 | FALSE | 0 | 0 |
2024-07-19 | 3.5 | 0 | PUT | 0 | 15 | 0 | FALSE | 0 | 0 |
2024-07-19 | 4 | 0 | PUT | 0 | 0 | 239.3 | FALSE | 0 | 0 |
2024-07-19 | 4.5 | 1 | PUT | 10 | 0 | 104.3 | TRUE | 1 | 0 |
2024-07-19 | 5 | 1.95 | PUT | 0 | 221 | 122.83 | TRUE | 0 | 0 |
2024-07-19 | 5.5 | 0 | PUT | 0 | 0 | 120.11 | TRUE | 0 | 0 |
2024-07-19 | 7.5 | 4.5 | PUT | 0 | 6 | 108.69 | TRUE | 0 | 0 |
2024-10-18 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-10-18 | 1 | 0 | CALL | 0 | 0 | 562.99 | TRUE | 0 | 0 |
2024-10-18 | 1.5 | 0 | CALL | 0 | 0 | 330.51 | TRUE | 0 | 0 |
2024-10-18 | 2 | 0 | CALL | 0 | 0 | 117.08 | TRUE | 0 | 0 |
2024-10-18 | 2.5 | 2.45 | CALL | 3 | 172 | 119.2 | TRUE | 2.45 | 0 |
2024-10-18 | 3 | 1.57 | CALL | 0 | 1 | 261.49 | TRUE | 0 | 0 |
2024-10-18 | 3.5 | 1.06 | CALL | 0 | 1 | 111.84 | TRUE | 0 | 0 |
2024-10-18 | 4 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-10-18 | 4.5 | 1.2 | CALL | 0 | 2 | 68.89 | FALSE | 0 | 0 |
2024-10-18 | 5 | 0.7 | CALL | 0 | 6 | 78.91 | FALSE | 0 | 0 |
2024-10-18 | 5.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 7.5 | 0.95 | CALL | 102 | 58 | 123.99 | FALSE | -0.05 | -0.05 |
2024-10-18 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 1 | 0.1 | PUT | 30 | 70 | 157.32 | FALSE | 0 | 0 |
2024-10-18 | 1.5 | 0 | PUT | 0 | 0 | 181.79 | FALSE | 0 | 0 |
2024-10-18 | 2 | 0 | PUT | 0 | 0 | 292.87 | FALSE | 0 | 0 |
2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 3 | 0 | PUT | 0 | 5 | 127.35 | FALSE | 0 | 0 |
2024-10-18 | 3.5 | 0 | PUT | 0 | 0 | 98.58 | FALSE | 0 | 0 |
2024-10-18 | 4 | 0 | PUT | 0 | 0 | 115.05 | FALSE | 0 | 0 |
2024-10-18 | 4.5 | 0 | PUT | 0 | 0 | 73.9 | TRUE | 0 | 0 |
2024-10-18 | 5 | 2.55 | PUT | 0 | 100 | 63.55 | TRUE | 0 | 0 |
2024-10-18 | 5.5 | 0 | PUT | 0 | 0 | 84.72 | TRUE | 0 | 0 |
2024-10-18 | 7.5 | 0 | PUT | 0 | 0 | 145.87 | TRUE | 0 | 0 |
2030-12-18 | 5 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
2030-12-18 | 10 | 9.1 | CALL | 5 | 35 | 0 | FALSE | 0.6 | 0.07 |
2030-12-18 | 15 | 5.2 | CALL | 13 | 156 | 0 | FALSE | 1.1 | 0.27 |
2030-12-18 | 20 | 0.05 | CALL | 106 | 1279 | 0 | FALSE | -0.39 | -0.89 |
2030-12-18 | 25 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
2030-12-18 | 30 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
2030-12-18 | 10 | 0.33 | PUT | 1 | 120 | 0 | TRUE | 0.13 | 0.65 |
2030-12-18 | 25 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
2030-12-18 | 30 | 0 | PUT | 0 | TRUE | 0 | 0 |
Latest GTHX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 6 | $4.04 |
Jun 13, 2022 7:59 PM EST | 1 | $4.04 |
Jun 13, 2022 7:59 PM EST | 1 | $4.04 |
Jun 13, 2022 7:59 PM EST | 6 | $4.04 |
Jun 13, 2022 7:59 PM EST | 22 | $4.04 |
G1 Therapeutics, Inc (GTHX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520184045/0001193125-20-184045-index.htm |
2019-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000003877719000031/0000038777-19-000031-index.htm |
2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000021545719006723/0000215457-19-006723-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000031506619001077/0000315066-19-001077-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000031506620000996/0000315066-20-000996-index.htm |
2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000083423720005254/0000834237-20-005254-index.htm |
2018-09-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000089924318024423/0000899243-18-024423-index.htm |
2018-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000089924318024426/0000899243-18-024426-index.htm |
2020-09-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000089924320024597/0000899243-20-024597-index.htm |
2019-01-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000090221919000004/0000902219-19-000004-index.htm |
2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000090221920000318/0000902219-20-000318-index.htm |
2020-09-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000090221920000423/0000902219-20-000423-index.htm |
2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000110465920016440/0001104659-20-016440-index.htm |
2018-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518272226/0001193125-18-272226-index.htm |
2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518274606/0001193125-18-274606-index.htm |
2018-09-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1560241/000119312518275435/0001193125-18-275435-index.htm |
2018-09-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1560241/000119312518277677/0001193125-18-277677-index.htm |
2018-09-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518277693/0001193125-18-277693-index.htm |
2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518320920/0001193125-18-320920-index.htm |
2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518334098/0001193125-18-334098-index.htm |
2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518344931/0001193125-18-344931-index.htm |
2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312518353411/0001193125-18-353411-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000119312519038160/0001193125-19-038160-index.htm |
2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519057423/0001193125-19-057423-index.htm |
2019-04-26 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1560241/000119312519122482/0001193125-19-122482-index.htm |
2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519125156/0001193125-19-125156-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1560241/000119312519129276/0001193125-19-129276-index.htm |
2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1560241/000119312519129321/0001193125-19-129321-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519143015/0001193125-19-143015-index.htm |
2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519172466/0001193125-19-172466-index.htm |
2019-06-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1560241/000119312519172654/0001193125-19-172654-index.htm |
2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519175173/0001193125-19-175173-index.htm |
2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519215313/0001193125-19-215313-index.htm |
2019-09-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000119312519244222/0001193125-19-244222-index.htm |
2019-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519259970/0001193125-19-259970-index.htm |
2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519284702/0001193125-19-284702-index.htm |
2019-12-23 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312519322646/0001193125-19-322646-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520005787/0001193125-20-005787-index.htm |
2020-02-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1560241/000119312520023079/0001193125-20-023079-index.htm |
2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1560241/000119312520031340/0001193125-20-031340-index.htm |
2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520050064/0001193125-20-050064-index.htm |
2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520072881/0001193125-20-072881-index.htm |
2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1560241/000119312520119076/0001193125-20-119076-index.htm |
2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1560241/000119312520119084/0001193125-20-119084-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520134886/0001193125-20-134886-index.htm |
2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520157789/0001193125-20-157789-index.htm |
2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520167680/0001193125-20-167680-index.htm |
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520184045/0001193125-20-184045-index.htm |
2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520210633/0001193125-20-210633-index.htm |
2020-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520259617/0001193125-20-259617-index.htm |
2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1560241/000119312520285553/0001193125-20-285553-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037143/0001209191-19-037143-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037144/0001209191-19-037144-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037146/0001209191-19-037146-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037147/0001209191-19-037147-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037152/0001209191-19-037152-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037154/0001209191-19-037154-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919119037157/0001209191-19-037157-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036290/0001209191-20-036290-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036294/0001209191-20-036294-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036295/0001209191-20-036295-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036298/0001209191-20-036298-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036301/0001209191-20-036301-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036305/0001209191-20-036305-index.htm |
2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000120919120036308/0001209191-20-036308-index.htm |
2018-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003853/0001562180-18-003853-index.htm |
2018-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/0001562180-18-003854-index.htm |
2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003987/0001562180-18-003987-index.htm |
2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003988/0001562180-18-003988-index.htm |
2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004187/0001562180-18-004187-index.htm |
2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004188/0001562180-18-004188-index.htm |
2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004189/0001562180-18-004189-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/0001562180-18-004208-index.htm |
2018-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004218/0001562180-18-004218-index.htm |
2018-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004219/0001562180-18-004219-index.htm |
2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/0001562180-18-004453-index.htm |
2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004454/0001562180-18-004454-index.htm |
2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004455/0001562180-18-004455-index.htm |
2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004595/0001562180-18-004595-index.htm |
2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004596/0001562180-18-004596-index.htm |
2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004597/0001562180-18-004597-index.htm |
2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004778/0001562180-18-004778-index.htm |
2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004822/0001562180-18-004822-index.htm |
2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/0001562180-18-004886-index.htm |
2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004904/0001562180-18-004904-index.htm |
2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004905/0001562180-18-004905-index.htm |
2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004984/0001562180-18-004984-index.htm |
2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018005114/0001562180-18-005114-index.htm |
2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218018005115/0001562180-18-005115-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000087/0001562180-19-000087-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000088/0001562180-19-000088-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000089/0001562180-19-000089-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000090/0001562180-19-000090-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000091/0001562180-19-000091-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000092/0001562180-19-000092-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000093/0001562180-19-000093-index.htm |
2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000094/0001562180-19-000094-index.htm |
2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000343/0001562180-19-000343-index.htm |
2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000344/0001562180-19-000344-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000551/0001562180-19-000551-index.htm |
2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019002766/0001562180-19-002766-index.htm |
2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019004017/0001562180-19-004017-index.htm |
2019-07-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019004099/0001562180-19-004099-index.htm |
2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218019004100/0001562180-19-004100-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000558/0001562180-20-000558-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000559/0001562180-20-000559-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000560/0001562180-20-000560-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001004/0001562180-20-001004-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001005/0001562180-20-001005-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001006/0001562180-20-001006-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001007/0001562180-20-001007-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001008/0001562180-20-001008-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001009/0001562180-20-001009-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020001010/0001562180-20-001010-index.htm |
2020-03-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002478/0001562180-20-002478-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002479/0001562180-20-002479-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002527/0001562180-20-002527-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002528/0001562180-20-002528-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002529/0001562180-20-002529-index.htm |
2020-04-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002798/0001562180-20-002798-index.htm |
2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002799/0001562180-20-002799-index.htm |
2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459018028125/0001564590-18-028125-index.htm |
2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1560241/000156459019005520/0001564590-19-005520-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459019018105/0001564590-19-018105-index.htm |
2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459019030200/0001564590-19-030200-index.htm |
2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459019040487/0001564590-19-040487-index.htm |
2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1560241/000156459020006846/0001564590-20-006846-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459020022056/0001564590-20-022056-index.htm |
2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459020036954/0001564590-20-036954-index.htm |
2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1560241/000156459020050581/0001564590-20-050581-index.htm |
G1 Therapeutics, Inc (GTHX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of G1 Therapeutics, Inc (GTHX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1040%Institutional Ownership: 9090%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-11-15 | BARCLAY A PHILLIPS | SVP & Chief Financial Officer | Sell | 5,000.00 | 39.92 | 199,591.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004597/0001562180-18-004597-index.htm |
2018-09-05 | Jennifer K. Moses | VP of Finance & Admin | Sell | 750.00 | 59.60 | 44,700.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/0001562180-18-003854-index.htm |
2018-09-04 | SETH RUDNICK | Director | Sell | 500.00 | 60.31 | 30,155.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003853/0001562180-18-003853-index.htm |
2018-10-04 | SETH RUDNICK | Director | Sell | 1,980.00 | 49.99 | 98,981.39 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004188/0001562180-18-004188-index.htm |
2018-11-05 | SETH RUDNICK | Director | Sell | 10,000.00 | 41.53 | 415,347.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004455/0001562180-18-004455-index.htm |
2018-12-04 | SETH RUDNICK | Director | Sell | 116.00 | 40.00 | 4,640.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004822/0001562180-18-004822-index.htm |
2018-10-03 | TERRY L MURDOCK | SVP of Development Operations | Sell | 3,519.00 | 49.18 | 173,064.42 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004187/0001562180-18-004187-index.htm |
2018-11-05 | TERRY L MURDOCK | SVP of Development Operations | Sell | 3,519.00 | 41.53 | 146,128.59 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004454/0001562180-18-004454-index.htm |
2018-12-03 | TERRY L MURDOCK | SVP of Development Operations | Sell | 3,523.00 | 38.54 | 135,779.24 | 0.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004778/0001562180-18-004778-index.htm |
2018-09-04 | SETH RUDNICK | Director | Buy | 10,000.00 | 0.39 | 3,900.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003853/0001562180-18-003853-index.htm |
2018-10-04 | SETH RUDNICK | Director | Buy | 10,000.00 | 0.39 | 3,900.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004188/0001562180-18-004188-index.htm |
2018-11-05 | SETH RUDNICK | Director | Buy | 10,000.00 | 0.39 | 3,900.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004455/0001562180-18-004455-index.htm |
2018-12-04 | SETH RUDNICK | Director | Buy | 9,393.00 | 0.39 | 3,663.27 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004822/0001562180-18-004822-index.htm |
2020-03-13 | Jennifer K. Moses | CFO | Buy | 2,000.00 | 3.72 | 7,440.00 | 11,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002529/0001562180-20-002529-index.htm |
2018-09-17 | Mark A. Velleca | President and CEO | Sell | 2,835.00 | 65.74 | 186,366.10 | 11,165.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003988/0001562180-18-003988-index.htm |
2018-10-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 943.00 | 40.80 | 38,478.27 | 11,233.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004219/0001562180-18-004219-index.htm |
2018-12-04 | SETH RUDNICK | Director | Sell | 9,884.00 | 39.31 | 388,506.43 | 116.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004822/0001562180-18-004822-index.htm |
2018-09-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 3,776.00 | 4.17 | 15,745.92 | 12,176.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003987/0001562180-18-003987-index.htm |
2018-10-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 3,776.00 | 4.17 | 15,745.92 | 12,176.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004219/0001562180-18-004219-index.htm |
2019-01-02 | Jay Strum | Chief Scientific Officer | Buy | 40,333.00 | 0.39 | 15,729.87 | 129,237.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000094/0001562180-19-000094-index.htm |
2018-09-17 | Mark A. Velleca | President and CEO | Buy | 5,000.00 | 3.72 | 18,600.00 | 14,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003988/0001562180-18-003988-index.htm |
2018-10-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 6,300.00 | 0.39 | 2,457.00 | 14,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004219/0001562180-18-004219-index.htm |
2018-11-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 247.00 | 40.31 | 9,957.56 | 14,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004595/0001562180-18-004595-index.htm |
2018-12-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 3,776.00 | 30.00 | 113,280.00 | 14,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004984/0001562180-18-004984-index.htm |
2018-11-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 3,529.00 | 39.71 | 140,147.18 | 14,947.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004595/0001562180-18-004595-index.htm |
2018-12-26 | Cynthia Schwalm | Director | Buy | 1,420.00 | 18.45 | 26,196.44 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018005114/0001562180-18-005114-index.htm |
2018-11-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 3,776.00 | 4.17 | 15,745.92 | 18,476.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004595/0001562180-18-004595-index.htm |
2018-12-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 3,776.00 | 4.17 | 15,745.92 | 18,476.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004984/0001562180-18-004984-index.htm |
2018-10-11 | Mark A. Velleca | President and CEO | Buy | 10,000.00 | 0.39 | 3,900.00 | 19,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004218/0001562180-18-004218-index.htm |
2018-10-15 | Mark A. Velleca | President and CEO | Sell | 2,837.00 | 42.01 | 119,176.70 | 19,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004218/0001562180-18-004218-index.htm |
2018-11-15 | Mark A. Velleca | President and CEO | Sell | 15.00 | 40.59 | 608.85 | 19,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004596/0001562180-18-004596-index.htm |
2018-11-15 | Mark A. Velleca | President and CEO | Sell | 4,985.00 | 39.84 | 198,601.90 | 19,015.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004596/0001562180-18-004596-index.htm |
2018-10-04 | SETH RUDNICK | Director | Sell | 8,020.00 | 49.65 | 398,229.09 | 1,980.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004188/0001562180-18-004188-index.htm |
2018-12-10 | James S. Hanson | General Counsel | Buy | 1,000.00 | 32.51 | 32,507.90 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004905/0001562180-18-004905-index.htm |
2018-09-05 | Jennifer K. Moses | VP of Finance & Admin | Buy | 2,000.00 | 3.72 | 7,440.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/0001562180-18-003854-index.htm |
2018-10-08 | Jennifer K. Moses | VP of Finance & Admin | Sell | 750.00 | 44.52 | 33,390.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/0001562180-18-004208-index.htm |
2018-11-05 | Jennifer K. Moses | VP of Finance & Admin | Sell | 750.00 | 41.38 | 31,035.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/0001562180-18-004453-index.htm |
2018-12-06 | Jennifer K. Moses | VP of Finance & Admin | Sell | 750.00 | 34.00 | 25,500.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/0001562180-18-004886-index.htm |
2019-01-28 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 7,000.00 | 0.39 | 2,730.00 | 21,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000551/0001562180-19-000551-index.htm |
2018-10-15 | Mark A. Velleca | President and CEO | Sell | 2,163.00 | 40.90 | 88,468.65 | 21,837.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004218/0001562180-18-004218-index.htm |
2018-10-15 | Mark A. Velleca | President and CEO | Buy | 5,000.00 | 3.72 | 18,600.00 | 24,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004218/0001562180-18-004218-index.htm |
2018-11-15 | Mark A. Velleca | President and CEO | Buy | 5,000.00 | 3.72 | 18,600.00 | 24,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004596/0001562180-18-004596-index.htm |
2020-01-23 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 5,000.00 | 0.39 | 1,950.00 | 26,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000558/0001562180-20-000558-index.htm |
2018-10-08 | Jennifer K. Moses | VP of Finance & Admin | Buy | 750.00 | 0.39 | 292.50 | 2,750.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/0001562180-18-004208-index.htm |
2018-11-05 | Jennifer K. Moses | VP of Finance & Admin | Buy | 750.00 | 0.39 | 292.50 | 2,750.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/0001562180-18-004453-index.htm |
2018-12-06 | Jennifer K. Moses | VP of Finance & Admin | Buy | 750.00 | 0.39 | 292.50 | 2,750.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/0001562180-18-004886-index.htm |
2019-01-17 | Mark A. Velleca | President and CEO | Buy | 9,000.00 | 0.39 | 3,510.00 | 28,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000343/0001562180-19-000343-index.htm |
2020-03-13 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Buy | 2,500.00 | 0.39 | 975.00 | 29,200.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002528/0001562180-20-002528-index.htm |
2018-12-26 | James S. Hanson | General Counsel | Buy | 1,000.00 | 18.25 | 18,250.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018005115/0001562180-18-005115-index.htm |
2020-01-23 | Mark A. Velleca | President and CEO | Buy | 6,000.00 | 0.39 | 2,340.00 | 34,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000560/0001562180-20-000560-index.htm |
2018-10-03 | TERRY L MURDOCK | SVP of Development Operations | Buy | 3,519.00 | 13.51 | 47,541.69 | 3,519.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004187/0001562180-18-004187-index.htm |
2018-11-05 | TERRY L MURDOCK | SVP of Development Operations | Buy | 3,519.00 | 13.51 | 47,541.69 | 3,519.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004454/0001562180-18-004454-index.htm |
2018-12-03 | TERRY L MURDOCK | SVP of Development Operations | Buy | 3,523.00 | 13.51 | 47,595.73 | 3,523.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004778/0001562180-18-004778-index.htm |
2020-03-13 | Mark A. Velleca | President and CEO | Buy | 3,000.00 | 0.39 | 1,170.00 | 37,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020002527/0001562180-20-002527-index.htm |
2020-09-04 | James S. Hanson | General Counsel | Buy | 1,000.00 | 14.95 | 14,950.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000089924320024597/0000899243-20-024597-index.htm |
2018-12-07 | Jennifer K. Moses | VP of Finance & Admin | Buy | 2,000.00 | 3.72 | 7,440.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/0001562180-18-004886-index.htm |
2018-10-04 | Jay Strum | Chief Scientific Officer | Buy | 850.00 | 0.30 | 255.00 | 49,419.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004189/0001562180-18-004189-index.htm |
2018-09-04 | SETH RUDNICK | Director | Sell | 9,500.00 | 59.93 | 569,328.35 | 500.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003853/0001562180-18-003853-index.htm |
2018-11-15 | BARCLAY A PHILLIPS | SVP & Chief Financial Officer | Buy | 5,000.00 | 19.46 | 97,300.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004597/0001562180-18-004597-index.htm |
2018-12-10 | JOHN DEMAREE | Chief Commercial Officer | Buy | 1,000.00 | 33.15 | 33,151.10 | 5,250.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004904/0001562180-18-004904-index.htm |
2019-01-17 | Jennifer K. Moses | VP of Finance | Buy | 2,000.00 | 3.72 | 7,440.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000344/0001562180-19-000344-index.htm |
2018-12-04 | SETH RUDNICK | Director | Buy | 607.00 | 0.39 | 236.73 | 607.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004822/0001562180-18-004822-index.htm |
2018-09-05 | Jennifer K. Moses | VP of Finance & Admin | Buy | 750.00 | 0.39 | 292.50 | 750.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/0001562180-18-003854-index.htm |
2019-07-18 | Jennifer K. Moses | CFO | Buy | 2,000.00 | 3.72 | 7,440.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019004017/0001562180-19-004017-index.htm |
2018-09-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 300.00 | 67.95 | 20,385.00 | 8,400.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003987/0001562180-18-003987-index.htm |
2018-10-15 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 2,833.00 | 42.01 | 119,018.58 | 8,400.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018004219/0001562180-18-004219-index.htm |
2018-09-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 484.00 | 66.77 | 32,317.02 | 8,700.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003987/0001562180-18-003987-index.htm |
2019-01-02 | Jay Strum | Chief Scientific Officer | Buy | 39,485.00 | 0.30 | 11,845.50 | 88,904.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218019000094/0001562180-19-000094-index.htm |
2020-01-23 | Jennifer K. Moses | CFO | Buy | 1,000.00 | 3.72 | 3,720.00 | 9,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218020000559/0001562180-20-000559-index.htm |
2018-09-17 | Mark A. Velleca | President and CEO | Sell | 300.00 | 67.95 | 20,385.00 | 9,000.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003988/0001562180-18-003988-index.htm |
2018-09-17 | Rajesh Malik | Ch. Medical Officer & SVP R&D | Sell | 2,992.00 | 65.78 | 196,799.70 | 9,184.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003987/0001562180-18-003987-index.htm |
2018-09-17 | Mark A. Velleca | President and CEO | Sell | 1,865.00 | 66.92 | 124,797.97 | 9,300.00 | https://www.sec.gov/Archives/edgar/data/1560241/000156218018003988/0001562180-18-003988-index.htm |